January 2005 Volume 1, Issue 1
Volume 1, Issue 1 | January 2005
January 2005
In this Issue
Global News
Agilent Technologies expands genomic microarray platform
Acquisition of Computational Biology provides key ChIP-on-Chip technology
Sign o’ the times? Drug discovery companies ramp up investments in China
Within a single week, two major players in the drug discovery instrumentation and reagent industry—Thermo Electron and Invitrogen—made moves to capitalize on the ever-strengthening Chinese biotechnology and pharmaceutical markets, further entrenching theThermo intros LeadStream
Integrated ADMETox platform aimed at easing preclinical bottleneck and lowering development attrition rates.Pellini named BioAdvance Entrepreneur-in-Residence
The Biotechnology Greenhouse of Southeastern Pennsylvania BioAdvance recently announced the selection of Dr. Michael Pellini as the organization’s inaugural Entrepreneur-in-Residence. Part of a $2-billion initiative by the Commonwealth of Pennsylvania toViroLogic and ACLARA merge
Company sees ‘explosive’ potential in targeted therapeuticsInformatics
Tripos acquires Optive Research
In a move that further broadens its offerings in bioinformatics software, Tripos Inc. closed its acquisition earlier this month for Austin, Texas-based Optive Research, a two-year old technology and software spinout of the University of Texas at Austin.Accelerator adds venture partners
Funding boosts capital pool by $11.8 million and adds informatics expertiseAmgen Ventures to fund emerging biotech companies
With $100 million in its coffers, Amgen Ventures, a corporate venture capital fund initiated by Amgen Inc. in late 2004, will provide monetary assistance for emerging biotechnology companies that work in Amgen’s areas of interest related to human therapeuNonlinear Dynamics, GenoLogics team up
After several months of discussions, GenoLogics Life Sciences Software Inc., based here, and Nonlinear Dynamics of Newcastle upon Tyne, England, have entered into a global partnership agreement that will result in an integrated protein informatics softwarNews Briefs
Bioinformatics News BriefsGenomics & Proteomics
Invitrogen launches Human ProtoArray
With more than 1,800 proteins on its surface, the new product marks the debut of high-density protein microarraysApplied Bio names CSO
Chief Scientific Officer leads convergence of technology, scienceNIST tackles gene expression QC
With the recent launch of the multidisciplinary Metrology for Gene Expression Program, the National Institute of Standards and Technology (NIST) is hoping to explore and address the challenges associated with the measurement, validation, and quality contrCiphergen sells BioSepra to Pall
Pall Corp. in late 2004 finalized the $32-million purchase of Ciphergen Biosystems Inc.’s process chromatography sorbent business. The acquisition of the BioSepra Process Division fills a crucial “missing link” in Pall’s extensive fluid management offerinGeron in license deal with Cambrex for distribution of telomeraze-immortalized human cell lines
Geron Corp. in January announced a worldwide license agreement with Cambrex Bio Science Walkersville Inc. under which the Cambrex subsidiary will develop and distribute cell lines that have been immortalized using Geron’s proprietary telomerase technologyNews Briefs
Genomics & Proteomics News BriefsAutomation & Instrumentation
Caliper Life Sciences licenses microfluidics patents to Predicant
Predicant becomes the first company to gain technology rights as Caliper adopts a more expansive out-licensing strategy for its intellectual property estateLab-on-a-chip takes next step
The lab-on-a-chip (LOC) field may be about to hit its stride with the recent introduction of a fully automated system by Agilent Technologies. Designed to replace gel electrophoresis steps, the Agilent 5100 ALP allows researchers to perform thousands of uPerkinElmer, Procognia team up for high–throughput protein array
Health science heavyweight PerkinElmer and proteomics technology developer Procognia announced in mid-December a co-marketing agreement that combines PE’s Protein Array Workstation and ProScan Array HT with Procognia’s U-c lectin array-based platform to cOptics specialist Bookham focuses on life sciences
In late 2004, Bookham New Focus introduced the Clarity line of fluorescence filters, developed for use in analytical and diagnostic instruments, including fluorescence microscopy, flow cytometry, DNA sequencing, microarrays, and other fluorescence applicaNews Briefs
Automation & Instrumentation News BriefsResearch & Development
Ricerca Biosciences expands
Ricerca Biosciences LLC in December completed a capacity expansion of its in vivo pre-clinical testing capability and was also in the process of a similar expansion in its medicinal chemistry and chemical development services. The additional capacity wasPlexxikon bolsters R&D
Success of company’s Scaffold-Based Drug Discovery platform puts it on development fast trackCalifornia Dreamin’: Proposition 71 puts stem cell research on fast track
Somewhat lost among the rising cheers of public and private research institutions after the passage of California Proposition 71, a measure that will provide nearly $3 billion in public funding in the state for stem cell research over the next 10 years, wNovasite gets NIH grant
Novasite Pharmaceuticals Inc. announced it has received a four-year grant valued at nearly $3.4 million for continued development of its proprietary parallel screening technology for G-Protein Coupled Receptors (GPCRs).News Briefs
Research Technology News Briefs
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Accelerating RNA therapeutic testing with liver microphysiological platforms
Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
